Cited by 877Immunotherapy and Immune ResponsesT-cell and B-cell ImmunologyCancer Immunotherapy and Biomarkers

The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.

Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes

Open access

Munn, David H., Sharma, Madhav D., Hou, Deyan, Baban, Babak, Lee, Jeffrey R., Antonia, Scott J., Messina, Jane L., Chandler, Phillip, Koni, Pandelakis A., Mellor, Andrew L.·2004·Journal of Clinical Investigation

DOI 10.1172/jci21583

Open this paper in CoChat — free account Open PDF

Abstract

One mechanism contributing to immunologic unresponsiveness toward tumors may be presentation of tumor antigens by tolerogenic host APCs.We show that mouse tumor-draining LNs (TDLNs) contained a subset of plasmacytoid DCs (pDCs) that constitutively expressed immunosuppressive levels of the enzyme indoleamine 2,3-dioxygenase (IDO).Despite comprising only 0.5% of LN cells, these pDCs in vitro potently suppressed T cell responses to antigens presented by the pDCs themselves and also, in a dominant fashion, suppressed T cell responses to third-party antigens presented by nonsuppressive APCs.Adoptive transfer of DCs from TDLNs into naive hosts created profound local T cell anergy, specifically toward antigens expressed by the transferred DCs.Anergy was prevented by targeted disruption of the IDO gene in the DCs or by administration of the IDO inhibitor drug 1-methyl-D-tryptophan to recipient mice.Within the population of pDCs, the majority of the functional IDO-mediated suppressor activity segregated with a novel subset of pDCs coexpressing the B-lineage marker CD19.We hypothesize that IDO-mediated suppression by pDCs in TDLNs creates a local microenvironment that is potently suppressive of host antitumor T cell responses.Nonstandard abbreviations used: indoleamine 2,3-dioxygenase (IDO); 1-methyl-D-tryptophan (1MT); mixed leukocyte reaction (MLR); plasmacytoid DC (pDC); regulatory T cell (Treg); T cell receptor (TCR); tumor-draining LN (TDLN). Conflict of interest:The authors have declared that no conflict of interest exists.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci21583

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

T cell receptor antagonist peptides induce positive selection.
Hogquist, K., Jameson, S., Heath, W., Howard, J. L., Bevan, M., & Carbone, F. (1994) · Cell · doi:10.1016/0092-8674(94)90169-4 · Cited by 3,252
Tolerogenic Dendritic Cells
Steinman, R. M., Hawiger, D., & Nussenzweig, M. C. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141040 · Cited by 3,162
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.
Dranoff, G., Jaffee, E. M., Lazenby, A., Golumbek, P. T., Levitsky, H., Brose, K., Jackson, V., Hamada, H., Pardoll, D. M., & Mulligan, R. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3539 · Cited by 2,820
Prevention of Allogeneic Fetal Rejection by Tryptophan Catabolism
Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I. E., Conway, S. J., Marshall, B., Brown, C. C., & Mellor, A. L. (1998) · Science · doi:10.1126/science.281.5380.1191 · Cited by 2,589
Self-citation
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
Uyttenhove, C., Pilotte, L., Théate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T., & Van den Eynde, B. J. (2003) · Nature Medicine · doi:10.1038/nm934 · Cited by 2,305
Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism
Munn, D. H., Shafizadeh, E., Attwood, J. T., Bondarev, I. E., Pashine, A., & Mellor, A. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.9.1363 · Cited by 1,640
Self-citation
Modulation of tryptophan catabolism by regulatory T cells
Fallarino, F., Grohmann, U., Hwang, K. W., Orabona, C., Vacca, C., Bianchi, R., Belladonna, M. L., Fioretti, M. C., Alegre, M., & Puccetti, P. (2003) · Nature Immunology · doi:10.1038/ni1003 · Cited by 1,375
CTLA-4–Ig regulates tryptophan catabolism in vivo
Grohmann, U., Orabona, C., Fallarino, F., Vacca, C., Calcinaro, F., Falorni, A., Candeloro, P., Belladonna, M. L., Bianchi, R., Fioretti, M. C., et al. (2002) · Nature Immunology · doi:10.1038/ni846 · Cited by 1,204
Commitment to the B-lymphoid lineage depends on the transcription factor Pax5
Nutt, S. L., Heavey, B., Rolink, A. G., & Busslinger, M. (1999) · Nature · doi:10.1038/44076 · Cited by 1,179
Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor Antigens
Huang, A. Y.-C., Golumbek, P. T., Ahmadzadeh, M., Jaffee, E. M., Pardoll, D. M., & Levitsky, H. I. (1994) · Science · doi:10.1126/science.7513904 · Cited by 1,159

Flagged first, then by citations

Show all 85 references

Research works printed but not linked: 2

Cuenca, 2003, Cancer Res., 63, 9007
Almand, 2000, Clin. Cancer Res., 6, 1755

Sorted by citations

Items 301–400 of 877

Heterogeneous Myeloid Cells in Tumors
Dou, A., & Fang, J. (2021) · Cancers · doi:10.3390/cancers13153772 · Cited by 68
The Role of Indoleamine 2, 3-Dioxygenase 1 in Regulating Tumor Microenvironment
Huang, X., Zhang, F., Wang, X., & Liu, K. (2022) · Cancers · doi:10.3390/cancers14112756 · Cited by 69
The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer
Gao, Y.-F., Peng, R., Li, J., Ding, Y., Zhang, X., Wu, X., Pan, Z., Wan, D.-S., Zeng, Y.-X., & Zhang, X. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-71 · Cited by 68
Incomplete Differentiation of Antigen-Specific CD8 T Cells in Tumor-Draining Lymph Nodes
Hargadon, K. M., Brinkman, C. C., Sheasley-O’Neill, S. L., Nichols, L. A., Bullock, T. N. J., & Engelhard, V. H. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6081 · Cited by 66
A high-affinity, tryptophan-selective amino acid transport system in human macrophages
Seymour, R. L., Ganapathy, V., Mellor, A. L., & Munn, D. H. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1205727 · Cited by 69
Self-citation
Targeting the Immunoregulatory Indoleamine 2,3 Dioxygenase Pathway in Immunotherapy
rd, B. A. J., Baban, B., & Mellor, A. L. (2009) · Immunotherapy · doi:10.2217/imt.09.21 · Cited by 65
Self-citation
The emerging role of viruses in the treatment of solid tumours
Bourke, M. G., Salwa, S., Harrington, K. J., Kucharczyk, M. J., Forde, P. F., de Kruijf, M., Soden, D. M., Tangney, M., Collins, J. K., & O’Sullivan, G. C. (2011) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.12.003 · Cited by 66
Immunotherapeutic Suppression of Indoleamine 2,3-Dioxygenase and Tumor Growth with Ethyl Pyruvate
Muller, A. J., DuHadaway, J. B., Jaller, D., Curtis, P. J., Metz, R. A., & Prendergast, G. C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3613 · Cited by 64
Immunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancer
Lavoué, V., Thedrez, A., Lévêque, J., Foucher, F., Henno, S., Jauffret, V., Belaud‐Rotureau, M., Catros, V., & Cabillic, F. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-147 · Cited by 64
Regulatory T Cells: From Discovery to AutoimmunityPreprint
Kitz, A., Singer, E. R., & Hafler, D. A. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a029041 · Cited by 71
Dendritic Cell–Based Vaccines that Utilize Myeloid Rather than Plasmacytoid Cells Offer a Superior Survival Advantage in Malignant Glioma
Dey, M., Chang, A. L., Miska, J. M., Wainwright, D. A., Ahmed, A. U., Balyasnikova, I. V., Pytel, P., Han, Y., Tobias, A. L., Zhang, L., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401607 · Cited by 63
Effects of 1-methyltryptophan stereoisomers on IDO2 enzyme activity and IDO2-mediated arrest of human T cell proliferation
Qian, F., Liao, J., Villella, J., Edwards, R. P., Kaliński, P., Lele, S., Shrikant, P. A., & Odunsi, K. O. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1265-x · Cited by 64
Recent discovery of indoleamine-2,3-dioxygenase 1 inhibitors targeting cancer immunotherapy
Weng, T., Qiu, X., Wang, J., Li, Z., & Bian, J. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.11.088 · Cited by 63
Breaking tolerance in cancer immunotherapy: time to ACT
Overwijk, W. W. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.01.011 · Cited by 63
Indoleamine 2,3-Dioxygenase Activity Contributes to Local Immune Suppression in the Skin Expressing Human Papillomavirus Oncoprotein E7
Mittal, D., Kassianos, A. J., Tran, L. S., Bergot, A., Gosmann, C., Hofmann, J., Blumenthal, A., Leggatt, G. R., & Frazer, I. H. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.222 · Cited by 62
Central Role of IFNγ–Indoleamine 2,3-Dioxygenase Axis in Regulation of Interleukin-12–Mediated Antitumor Immunity
Gu, T., Rowswell-Turner, R. B., Kilinc, M. O., & Egilmez, N. K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-3170 · Cited by 62
Immune Dysregulation by the Rheumatoid Arthritis Shared Epitope
de Almeida, D. E., Ling, S., Pi, X., Hartmann-Scruggs, A. M., Pumpens, P., & Holoshitz, J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904002 · Cited by 61
Deletion of LRP5 and LRP6 in dendritic cells enhances antitumor immunity
Yuan, H., Manoharan, I., Suryawanshi, A. S., Shanmugam, A., Swafford, D., Ahmad, S., Chinnadurai, R., Manicassamy, B., He, Y., Mellor, A. L., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1115941 · Cited by 61
Self-citation
IDO2 Modulates T Cell–Dependent Autoimmune Responses through a B Cell–Intrinsic Mechanism
Merlo, L. M. F., DuHadaway, J. B., Grabler, S., Prendergast, G. C., Muller, A. J., & Mandik‐Nayak, L. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600141 · Cited by 62
Tumor microenvironmental influences on dendritic cell and T cell function: A focus on clinically relevant immunologic and metabolic checkpoints
Hargadon, K. M. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.37 · Cited by 63
Generation of immunogenic and tolerogenic clinical-grade dendritic cells
Kalantari, T., Kamali‐Sarvestani, E., Ćirić, B., Karimi, M. H., Kalantari, M., Faridar, A., Xu, H., & Rostami, A. M. (2011) · Immunologic Research · doi:10.1007/s12026-011-8255-5 · Cited by 60
Carbohydrate and Amino Acid Metabolism as Hallmarks for Innate Immune Cell Activation and Function
Zhao, H., Raines, L. N., & Huang, S. C. (2020) · Cells · doi:10.3390/cells9030562 · Cited by 62
Histone deacetylase-mediated tumor microenvironment characteristics and synergistic immunotherapy in gastric cancer
Lin, Y., Jing, X., Chen, Z., Pan, X., Xu, D., Yu, X., Zhong, F., Zhao, L., Yang, C., Wang, B., et al. (2023) · Theranostics · doi:10.7150/thno.86928 · Cited by 62
Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitry
Nguyen, T. T., Shin, D. H., Sohoni, S. S., Singh, S. K., Rivera-Molina, Y. A., Jiang, H., Fan, X., Gumin, J., Lang, F. F., Alvarez-Breckenridge, C. A., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004935 · Cited by 62
Indoleamine 2,3-dioxygenase gene transfer prolongs cardiac allograft survival
Li, J., Meinhardt, A., Roehrich, M.-E., Golshayan, D., Dudler, J., Pagnotta, M., Trucco, M., & Vassalli, G. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00532.2007 · Cited by 61
Induction and Role of Indoleamine 2,3 Dioxygenase in Mouse Models of Influenza A Virus Infection
Huang, L., Li, L., Klonowski, K., Tompkins, S. M., Tripp, R. A., & Mellor, A. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066546 · Cited by 59
Self-citation
Personalized Dendritic Cell-Based Tumor Immunotherapy
Janikashvili, N., Larmonier, N., & Katsanis, E. (2009) · Immunotherapy · doi:10.2217/imt.09.78 · Cited by 62
Immunomodulation of Curcumin on Adoptive Therapy with T Cell Functional Imaging in Mice
Chang, Y.-F., Chuang, H., Hsu, C.-H., Liu, R.-S., Gambhir, S. S., & Hwang, J. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0308 · Cited by 59
Dendritic cell immunotherapy
Sabado, R. L., & Bhardwaj, N. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12125 · Cited by 61
Immune Heterogeneity in Neuroinflammation: Dendritic Cells in the Brain
Colton, C. A. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9414-8 · Cited by 59
Indoleamine 2,3-dioxygenase-expressing dendritic cells are involved in the generation of CD4+CD25+regulatory T cells in Peyer's patches in an orally tolerized, collagen-induced arthritis mouse model
Park, M.-J., Min, S., Park, K.-S., Cho, Y. G., Cho, M., Jung, Y., Park, H.-S., Chang, S.-H., Cho, S., Min, J., et al. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2361 · Cited by 58
Inhibitors of human indoleamine 2,3‐dioxygenase identified with a target‐based screen in yeast
Vottero, E., Balgi, A. D., Woods, K., Tugendreich, S., Mélèse, T., Andersen, R. J., Mauk, A. G., & Roberge, M. (2006) · Biotechnology Journal · doi:10.1002/biot.200600001 · Cited by 57
1-l-methyltryptophan is a more effective inhibitor of vertebrate IDO2 enzymes than 1-d-methyltryptophan
Yuasa, H. J., Ball, H. J., Austin, C., & Hunt, N. H. (2010) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2010.04.006 · Cited by 58
Metabolic remodeling contributes towards an immune-suppressive phenotype in glioblastoma
Kesarwani, P., Prabhu, A. H., Kant, S., & Chinnaiyan, P. (2019) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-019-02347-3 · Cited by 56
Tryptophan Metabolism in Atherosclerosis and Diabetes
Sudar-Milovanovic, E. M., Gluvic, Z. M., Obradovic, M. M., Zarić, B. L., & Isenović, E. R. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210714153649 · Cited by 57
Two distinct activation states of plasmacytoid dendritic cells induced by influenza virus and CpG 1826 oligonucleotide
Iparraguirre, A., Tobias, J. W., Hensley, S. E., Masek, K. S., Cavanagh, L. L., Rendl, M., Hunter, C. A., Ertl, H. C. J., von Andrian, U. H., & Weninger, W. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0807511 · Cited by 56
Plasmacytoid dendritic cells, a role in neoplastic prevention and progression
Lombardi, V. C., Khaiboullina, S. F., & Rizvanov, A. A. (2014) · European Journal of Clinical Investigation · doi:10.1111/eci.12363 · Cited by 55
Emerging role of dendritic cells in respiratory viral infection
Grayson, M. H., & Holtzman, M. J. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0212-3 · Cited by 55
The interplay between metabolic remodeling and immune regulation in glioblastoma
Kesarwani, P., Kant, S., Prabhu, A. H., & Chinnaiyan, P. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox079 · Cited by 56
Indoleamine Dioxygenase Inhibitors: Clinical Rationale and Current Development
Zhu, M. M. T., Dancsok, A. R., & Nielsen, T. O. (2019) · Current Oncology Reports · doi:10.1007/s11912-019-0750-1 · Cited by 55
P2Y receptor signaling regulates phenotype and IFN-α secretion of human plasmacytoid dendritic cells
Shin, A., Toy, T., Rothenfußer, S., Robson, N. C., Vorac, J., Dauer, M., Stuplich, M., Endres, S., Cebon, J. S., Maraskovsky, E., et al. (2007) · Blood · doi:10.1182/blood-2007-02-071910 · Cited by 55
What is the prospect of indoleamine 2,3-dioxygenase 1 inhibition in cancer? Extrapolation from the past
Yu, Y., Liang, H., Fang, X., Zhang, S., Xing, Z., Shi, L., Kuang, C., Seliger, B., & Yang, Q. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01847-4 · Cited by 55
SOCS2-Induced Proteasome-Dependent TRAF6 Degradation: A Common Anti-Inflammatory Pathway for Control of Innate Immune Responses
McBerry, C., Gonzalez, R. M. S., Shryock, N., Dias, A., & Aliberti, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038384 · Cited by 58
Modulation of dendritic cell maturation and function with mono‐ and bifunctional small interfering RNAs targeting indoleamine 2,3‐dioxygenase
Flatekval, G. F., & Sioud, M. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03093.x · Cited by 56
Overexpression of Indoleamine 2,3-Dioxygenase in Human Endometrial Carcinoma Cells Induces Rapid Tumor Growth in a Mouse Xenograft Model
Yoshida, N., Ino, K., Ishida, Y., Kajiyama, H., Yamamoto, E., Shibata, K., Terauchi, M., Nawa, A., Akimoto, H., Takikawa, O., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0991 · Cited by 54
A Crucial Role for Host APCs in the Induction of Donor CD4+CD25+ Regulatory T Cell-Mediated Suppression of Experimental Graft-versus-Host Disease
Tawara, I., Shlomchik, W. D., Jones, A., Zou, W., Nieves, E. C., Liu, C., Toubai, T., Duran‐Struuck, R., Sun, Y., Clouthier, S. G., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001625 · Cited by 55
Non-hematopoietic expression of IDO is integrally required for inflammatory tumor promotion
Muller, A. J., DuHadaway, J. B., Chang, M. Y., Ramalingam, A., Sutanto‐Ward, E., Boulden, J., Soler, A. P., Mandik‐Nayak, L., Gilmour, S. K., & Prendergast, G. C. (2010) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0891-4 · Cited by 53
Enhanced tryptophan degradation in patients with ovarian carcinoma correlates with several serum soluble immune activation markers
Sperner‐Unterweger, B., Neurauter, G., Klieber, M., Kurz, K., Meraner, V., Zeimet, A. G., & Fuchs, D. (2010) · Immunobiology · doi:10.1016/j.imbio.2010.07.010 · Cited by 53
Local immunosuppression induced by high viral load of human papillomavirus: characterization of cellular phenotypes producing interleukin‐10 in cervical neoplastic lesions
Prata, T. T. M., Bonin, C. M., Ferreira, A. M. T., Padovani, C. T. J., Fernandes, C. E., Machado, A. P., & Tozetti, I. A. (2015) · Immunology · doi:10.1111/imm.12487 · Cited by 53
Dendritic Cells in Oncolytic Virus-Based Anti-Cancer Therapy
Kim, Y., Clements, D. R., Sterea, A. M., Jang, H. G., Gujar, S. A., & Lee, P. C. (2015) · Viruses · doi:10.3390/v7122953 · Cited by 53
Virus Infections Incite Pain Hypersensitivity by Inducing Indoleamine 2,3 Dioxygenase
Huang, L., Ou, R., de Souza, G. R., Cunha, T. M., Lemos, H. D. P., Mohamed, E. T., Li, L., Pacholczyk, G. A., Randall, J. R., Munn, D. H., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005615 · Cited by 53
Self-citation
Current Status of Clinical Trials for Cervical and Uterine Cancer Using Immunotherapy Combined With Radiation
Dyer, B. A., Feng, C. H., Eskander, R. N., Sharabi, A. B., Mell, L. K., McHale, M. T., & Mayadev, J. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.09.016 · Cited by 52
Novel immunotherapies for hematologic malignancies
Nelson, M. H., & Paulos, C. M. (2014) · Immunological Reviews · doi:10.1111/imr.12245 · Cited by 52
CD8α+, but Not CD8α−, Dendritic Cells Tolerize Th2 Responses via Contact-Dependent and -Independent Mechanisms, and Reverse Airway Hyperresponsiveness, Th2, and Eosinophil Responses in a Mouse Model of Asthma
Gordon, J., Li, F., Nayyar, A., Xiang, J., & Zhang, X. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.3.1516 · Cited by 52
STAT3- and STAT5-dependent pathways competitively regulate the pan-differentiation of CD34pos cells into tumor-competent dendritic cells
Cohen, P. A., Koski, G. K., Czerniecki, B. J., Bunting, K. D., Fu, X.-Y., Wang, Z., Zhang, W., Carter, C. S., Awad, M., Distel, C. A., et al. (2008) · Blood · doi:10.1182/blood-2007-12-130138 · Cited by 52
Anti-CTLA4 antibody clinical trials in melanoma
Ribas, A. (2007) · Update on Cancer Therapeutics · doi:10.1016/j.uct.2007.09.001 · Cited by 51
Indoleamine 2,3-Dioxygenase+ Cells Correspond to the BDCA2+ Plasmacytoid Dendritic Cells in Human Melanoma Sentinel Nodes
Gerlini, G., Gennaro, P. D., Mariotti, G., Urso, C., Chiarugi, A., Pimpinelli, N., & Borgognoni, L. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.307 · Cited by 51
Immunotherapy in Cancer: A Combat between Tumors and the Immune System; You Win Some, You Lose Some
Rowdo, F. P. M., Barón, A., Urrutia, M., & Mordoh, J. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00127 · Cited by 51
Human Activated T Lymphocytes Modulate IDO Expression in Tumors through Th1/Th2 Balance
Godin-Ethier, J., Pelletier, S., Hanafi, L., Gannon, P. O., Forget, M., Routy, J., Boulassel, M., Krzemien, U., Tanguay, S., Lattouf, J., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901004 · Cited by 51
Dendritic Cells Secrete the Immunosuppressive HLA-G Molecule upon CTLA4-Ig Treatment: Implication in Human Renal Transplant Acceptance
Bahri, R., Naji, A., Menier, C., Charpentier, B., Carosella, E. D., Rouas‐Freiss, N., & Dürrbach, A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803054 · Cited by 55
Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer
Carvajal‐Hausdorf, D., Mani, N. L., Velcheti, V., Schalper, K. A., & Rimm, D. L. (2017) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-017-0285-7 · Cited by 51
Indoleamine 2,3-Dioxygenase and Regulatory Function: Tryptophan Starvation and Beyond
Orabona, C., & Grohmann, U. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-869-0_19 · Cited by 51
Trial Watch—Small molecules targeting the immunological tumor microenvironment for cancer therapy
Buqué, A., Bloy, N., Aranda, F., Cremer, I., Eggermont, A. M. M., Fridman, W. H., Fucikova, J. P., Galon, J., Špíšek, R., Tartour, É., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1149674 · Cited by 50
TGF-β–Exposed Plasmacytoid Dendritic Cells Participate in Th17 Commitment
Bonnefoy, F., Couturier, M., Clauzon, A., Rémy-Martin, J.-P., Gaugler, B., Tiberghien, P., Chen, W., Saas, P., & Perruche, S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002497 · Cited by 58
Mechanisms involved in synergistic anticancer effects of anti-4-1BB and cyclophosphamide therapy
Kim, Y. H., Choi, B. K., Oh, H. S., Kang, W. J., Mittler, R. S., & Kwon, B. S. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0993 · Cited by 50
Human tumor-specific T lymphocytes: does function matter more than number?
Coulie, P. G., & Connerotte, T. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.03.002 · Cited by 50
Immune cell profile of sentinel lymph nodes in patients with malignant melanoma – FOXP3+ cell density in cases with positive sentinel node status is associated with unfavorable clinical outcome
Mohos, A., Sebestyén, T., Liszkay, G., Plótár, V., Horváth, S., Gaudi, I., & Ladányi, A. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-43 · Cited by 49
Plasmacytoid dendritic cell proliferations and neoplasms involving the bone marrow
Tzankov, A., Hebeda, K. M., Kremer, M., Leguit, R. J., Orazi, A., van der Walt, J. D., & Gianelli, U. (2017) · Annals of Hematology · doi:10.1007/s00277-017-2947-4 · Cited by 49
Plasmacytoid Dendritic Cells in Tolerance
Gehrie, E. A., van der Touw, W., Bromberg, J. S., & Ochando, J. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-869-0_9 · Cited by 48
B-lymphoid cells with attributes of dendritic cells regulate T cells via indoleamine 2,3-dioxygenase
Johnson, B. A., Kahler, D. J., Baban, B., Chandler, P., Kang, B., Shimoda, M., Koni, P. A., Pihkala, J. P. S., Vilagos, B., Busslinger, M., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914347107 · Cited by 51
Self-citation
IDO Induces Expression of a Novel Tryptophan Transporter in Mouse and Human Tumor Cells
Silk, J. D., Lakhal‐Littleton, S., Laynes, R., Vallius, L., Karydis, I., Marcea, C., Boyd, C. A. R., & Cerundolo, V. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1000815 · Cited by 48
Active and Passive Immunotherapy for Lymphoma: Proving Principles and Improving Results
Brody, J., Kohrt, H. E. K., Marabelle, A., & Levy, R. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.4623 · Cited by 48
Bifunctional Naphthoquinone Aromatic Amide-Oxime Derivatives Exert Combined Immunotherapeutic and Antitumor Effects through Simultaneous Targeting of Indoleamine-2,3-dioxygenase and Signal Transducer and Activator of Transcription 3
Huang, R.-Z., Jing, X.-T., Huang, X., Pan, Y.-M., Fang, Y., Liang, G.-B., Liao, Z., Wang, H., Chen, Z., & Zhang, Y. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01386 · Cited by 48
Immunosuppressive profiles in liquid biopsy at diagnosis predict response to neoadjuvant chemotherapy in triple-negative breast cancer
Coloma, C. S., Santaballa, A., Sanmartín, E., Calvo, D. C., García, A., Hervás, D., Cordón, L., Quintás‐Cardama, A., Ripoll, F., Panadero, J., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.08.020 · Cited by 48
Melanoma‐derived factors alter the maturation and activation of differentiated tissue‐resident dendritic cells
Hargadon, K. M., Bishop, J. D., Brandt, J. P., Hand, Z. C., Ararso, Y., & Forrest, O. A. (2015) · Immunology and Cell Biology · doi:10.1038/icb.2015.58 · Cited by 49
Meningeal dendritic cells drive neuropathic pain through elevation of the kynurenine metabolic pathway in mice
Maganin, A. G. M., de Souza, G. R., Fonseca, M. M., Lopes, A. H., Guimarães, R. M., Dagostin, A., Cecílio, N. T., Mendes, A. S., Gonçalves, W. A., Silva, C. E. A., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci153805 · Cited by 48
Self-citation
High serum concentration of L-kynurenine predicts unfavorable outcomes in patients with acute myeloid leukemia
Mabuchi, R., Hara, T., Matsumoto, T., Shibata, Y., Nakamura, N., Nakamura, H., Kitagawa, J., Kanemura, N., Goto, N., Shimizu, M., et al. (2015) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2015.1041388 · Cited by 47
IDO-Mediated Tryptophan Degradation in the Pathogenesis of Malignant Tumor Disease
Sucher, R., Kurz, K., Weiß, G., Margreiter, R., Fuchs, D., & Brandacher, G. (2010) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s4157 · Cited by 47
Quality of CD8 + T cell immunity evoked in lymph nodes is compartmentalized by route of antigen transport and functional in tumor context
O’Melia, M. J., Rohner, N. A., Manspeaker, M. P., Francis, D. M., Kissick, H. T., & Thomas, S. N. (2020) · Science Advances · doi:10.1126/sciadv.abd7134 · Cited by 47
Immunosuppression Routed Via the Kynurenine Pathway: A Biochemical and Pathophysiologic Approach
González, Á., Varo, N., Alegre, E., Díaz, A. A., & Melero, I. (2008) · Advances in clinical chemistry · doi:10.1016/s0065-2423(07)00007-8 · Cited by 49
Indoleamine 2,3‐dioxygenase in transplantation (Review Article)
Mulley, W. R., & Nikolic‐Paterson, D. J. (2008) · Nephrology · doi:10.1111/j.1440-1797.2007.00921.x · Cited by 48
Tumor stroma-associated antigens for anti-cancer immunotherapy
Hofmeister, V., Vetter, C. S., Schrama, D., Bröcker, E., & Becker, J. C. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0070-1 · Cited by 47
Glioblastoma: Relationship between Metabolism and Immunosuppressive Microenvironment
Hernández, A., Doménech, M., Muñoz-Mármol, A. M., Carrato, C., & Balañá, C. (2021) · Cells · doi:10.3390/cells10123529 · Cited by 47
Endoplasmic reticulum stress response and inflammatory cytokines in type 2 diabetic nephropathy: Role of indoleamine 2,3-dioxygenase and programmed death-1
Baban, B., Liu, J. Y., & Mozaffari, M. S. (2012) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2012.11.004 · Cited by 46
Self-citation
Differential immunosuppressive effect of indoleamine 2,3-dioxygenase (IDO) on primary human CD4+ and CD8+ T cells
Forouzandeh, F., Jalili, R. B., Germain, M., Duronio, V., & Ghahary, A. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9635-y · Cited by 46
Inhibition of increased indoleamine 2,3-dioxygenase activity attenuates Toxoplasma gondii replication in the lung during acute infection
Murakami, Y., Hoshi, M., Hara, A., Takemura, M., Arioka, Y., Yamamoto, Y., Matsunami, H., Funato, T., Seishima, M., & Saito, K. (2012) · Cytokine · doi:10.1016/j.cyto.2012.04.022 · Cited by 46
Silencing of indoleamine 2,3-dioxygenase enhances dendritic cell immunogenicity and antitumour immunity in cancer patients
Sioud, M., Sæbøe‐Larssen, S., Falkenthal, T. E. H., Kærn, J., Mobergslien, A., & Kvalheim, G. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1922 · Cited by 47
Cellular Immunotherapy of Cancer
Okur, F. V., & Brenner, M. K. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-786-0_19 · Cited by 46
The Plasmacytoid Dendritic Cell as the Swiss Army Knife of the Immune System: Molecular Regulation of Its Multifaceted Functions
Karrich, J. J., Jachimowski, L. C. M., Uíttenbogaart, C. H., & Blom, B. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401541 · Cited by 50
Dendritic Cells as Killers: Mechanistic Aspects and Potential Roles
Chauvin, C., & Josien, R. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.11 · Cited by 45
Dendritic Cell Tumor Killing Activity and Its Potential Applications in Cancer Immunotherapy
Hanke, N. T., Alizadeh, D., Katsanis, E., & Larmonier, N. (2013) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2013006679 · Cited by 46
Bin1 Ablation in Mammary Gland Delays Tissue Remodeling and Drives Cancer Progression
Chang, M. Y., Boulden, J., Sutanto‐Ward, E., DuHadaway, J. B., Soler, A. P., Muller, A. J., & Prendergast, G. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2742 · Cited by 47
Leukocyte Infiltration in Cancer Creates an Unfavorable Environment for Antitumor Immune Responses: A Novel Target for Therapeutic Intervention
Bronte, V., Cingarlini, S., Marigo, I., Santo, C. D., Gallina, G., Dolcetti, L., Ugel, S., Peranzoni, E., Mandruzzato, S., & Zanovello, P. (2006) · Immunological Investigations · doi:10.1080/08820130600754994 · Cited by 45
Rosmarinic acid inhibits indoleamine 2,3-dioxygenase expression in murine dendritic cells
Lee, H. J., Jeong, Y.-I., Lee, T.-H., Jung, I. D., Lee, J. S., Lee, C.-M., Kim, J., Joo, H. Y., Lee, J.-D., & Park, Y. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.12.018 · Cited by 46
Self-citation
(–)-Epigallocatechin gallate suppresses indoleamine 2,3-dioxygenase expression in murine dendritic cells: Evidences for the COX-2 and STAT1 as potential targets
Jeong, Y.-I., Jung, I. D., Lee, J. S., Lee, C.-M., Lee, J.-D., & Park, Y. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.01.076 · Cited by 45
Self-citation
Blockade of IDO Inhibits Nasal Tolerance Induction
van der Marel, A. P. J., Samsom, J. N., Greuter, M., van Berkel, L. A., O’Toole, T. G., Kraal, G., & Mebius, R. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.2.894 · Cited by 46
Up-regulated expression of indoleamine 2,3-dioxygenase 1 in non-Hodgkin lymphoma correlates with increased regulatory T-cell infiltration
Liu, X.-Q., Lu, K., Feng, L., Ding, M., Gao, J., Ge, X., & Wang, X. (2013) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2013.804917 · Cited by 45
Metabolic mechanisms of cancer-induced inhibition of immune responses
Viola, A., & Bronte, V. (2007) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2007.06.005 · Cited by 45
Therapeutics targeting tumor immune escape: Towards the development of new generation anticancer vaccines
D, S. M. M., & Nitti, D. (2007) · Medicinal Research Reviews · doi:10.1002/med.20110 · Cited by 44
Diffuse intrinsic pontine glioma (DIPG): A review of current and emerging treatment strategies
Weisbrod, L. J., Anand, T., Vengoji, R., Shonka, N., Jain, M., Ho, W. S., Batra, S. K., & Salehi, A. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216876 · Cited by 44

Authors: Munn, D. H., Sharma, M. D., Hou, D., Baban, B., Lee, J. R., Antonia, S. J., Messina, J. L., Chandler, P., Koni, P. A., & Mellor, A. L.
Affiliations: Augusta University (US)
University of South Florida (US)
Corresponding author: Munn, David H.
ORCID: Munn, David H.
Sharma, Madhav D.
Baban, Babak
Antonia, Scott J.
Messina, Jane L.
Koni, Pandelakis A.
Mellor, Andrew L.
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 2004-07-15
Volume: 114
Issue: 2
Pages: 280-290
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci21583
OpenAlex: W2143565660
Cited by: 852
References: 85
Citations by year: 2026: 13 · 2025: 12 · 2024: 24 · 2023: 15 · 2022: 32 · 2021: 37 · 2020: 34 · 2019: 29 · 2018: 31 · 2017: 40 · 2016: 27 · 2015: 45 · 2014: 38 · 2013: 53 · 2012: 39
FWCI: 19.19
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed (publishedVersion)
Funders: Carlos and Marguerite Mason Trust
National Institutes of Health
National Cancer Institute (R01CA096651, R01 CA103220)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD041187)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords: indoleamine 2,3-dioxygenase, plasmacytoid dendritic cells, tumor-draining lymph nodes, immunosuppression, T cell anergy, tumor antigen presentation, CD19, 1-methyl-D-tryptophan, antitumor immunity, regulatory T cells, mixed lymphocyte reaction
MeSH terms: Animals, Antigen-Presenting Cells, Dendritic Cells, Female, Humans, Immunosuppression Therapy, Lymph Nodes, Lymphocyte Activation, Mice, Inbred Strains, Neoplasms, Random Allocation, T-Lymphocytes, Tryptophan Oxygenase, Survival Rate, Mice, Knockout, Antigens, CD19, Adoptive Transfer, CD11c Antigen, Indoleamine-Pyrrole 2,3,-Dioxygenase, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks